OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
WORX
SCWorx Corp.
There isn't enough reported data to score WORX yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
WORX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
WORX's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
WORX PE Valuation
WORX has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
WORX Forward outlook
There aren't enough analyst estimates for WORX to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the stronger earnings trend. Trailing diluted EPS is up 147% for OSCR versus WORX down 131%.
WORX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$174.60 | +$397.80 |
| Q2 2025 | -$196.20 | +$462.60 |
| Q1 2025 | -$160.20 | +$478.80 |
| Q4 2024 | -$140.40 | +$554.40 |
| Q3 2024 | -$572.40 | -$302.40 |
| Q2 2024 | -$658.80 | -$442.80 |
| Q1 2024 | -$639.00 | -$315.00 |
| Q4 2023 | -$694.80 | -$289.80 |
WORX is still losing money, but far less than before: $174.60 per share over the past year, against $972.00 at its worst in late 2021.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over WORX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over WORX on profitability, with a higher operating margin.
WORX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $706K | +3.4% |
| Q1 2026 | $744.9K | +3.4% |
| Q4 2025 | $768.9K | +14% |
| Q3 2025 | $705.8K | -7.1% |
| Q2 2025 | $682.6K | -8% |
| Q1 2025 | $720.3K | -11% |
| Q4 2024 | $675.7K | -26% |
| Q3 2024 | $759.7K | -16% |
WORX's revenue fell from its 2019 peak and has held roughly level since: $706,049 last quarter, up 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -17% | +26 points |
| Q1 2026 | -18% | +28 points |
| Q4 2025 | -25% | +31 points |
| Q3 2025 | -20% | +32 points |
| Q2 2025 | -43% | -1.6 points |
| Q1 2025 | -46% | -24 points |
| Q4 2024 | -56% | -51 points |
| Q3 2024 | -52% | +43 points |
WORX's operating margin was −17% last quarter, up 26 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the stronger cash trend. Its trailing FCF is up 545% versus its history, compared with WORX at down 25%.
WORX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.7K | +$646.1K |
| Q1 2026 | -$252.7K | +$151.9K |
| Q3 2025 | -$358.1K | +$4.5K |
| Q2 2025 | -$651.8K | -$124.1K |
| Q1 2025 | -$404.6K | -$345.1K |
| Q4 2024 | -$134.4K | -$29.6K |
| Q3 2024 | -$362.6K | +$10.2K |
| Q2 2024 | -$527.8K | -$180K |
WORX has burned cash in almost every quarter: −$1M over the past year, against −$1M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over WORX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
WORX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +852 shares |
| 1 year | +735% | +78.6K shares |
| 3 years | +1897% | +84.8K shares |
| 5 years | +2406% | +85.7K shares |
WORX has 89,269 diluted shares, up 735% from a year ago.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
WORX Net Leverage
WORX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
WORX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.5 | Neutral |
| Stochastic | 4.1 | Oversold |
WORX's weekly RSI is 36 (neutral) and its Stochastic is 4 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
WORX PE vs Healthcare Sector
WORX has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over WORX on trend strength, trading above more of its moving averages.
WORX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.39 | 47% below |
| 20 week MA | $4.13 | 69% below |
| 50 week MA | $19.4 | 93% below |
| 100 week MA | $80.5 | 98% below |
| 200 week MA | $313.5 | 100% below |
WORX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over WORX on returns for 2026, with the stronger performance.
WORX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7,722.0 | $4,104.0 | -47% |
| 2021 | $4,104.0 | $3,699.0 | -9.9% |
| 2022 | $3,699.0 | $1,107.0 | -70% |
| 2023 | $1,107.0 | $331.2 | -70% |
| 2024 | $331.2 | $302.4 | -8.7% |
| 2025 | $302.4 | $37.8 | -88% |
| 2026 YTD | $37.8 | $1.27 | -97% |
WORX has finished every year since 2020 lower, and it's down 97% so far in 2026.